OncoSec Medical Valuation
| ONCSDelisted Stock | USD 0.0002 0.00 0.00% |
OncoSec Medical seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of OncoSec Medical from analyzing the company fundamentals such as Return On Equity of -4.1, shares outstanding of 5.96 M, and Shares Owned By Institutions of 5.83 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors support acquiring undervalued entities and selling overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that OncoSec Medical's price fluctuation is very steady at this time. Calculation of the real value of OncoSec Medical is based on 3 months time horizon. Increasing OncoSec Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for OncoSec Medical is useful when determining the fair value of the OncoSec stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of OncoSec Medical. Since OncoSec Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OncoSec Stock. However, OncoSec Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0E-4 | Real 1.9E-4 | Hype 2.5E-4 |
The real value of OncoSec Stock, also known as its intrinsic value, is the underlying worth of OncoSec Medical Company, which is reflected in its stock price. It is based on OncoSec Medical's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of OncoSec Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OncoSec Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of OncoSec Medical helps investors to forecast how OncoSec stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OncoSec Medical more accurately as focusing exclusively on OncoSec Medical's fundamentals will not take into account other important factors: OncoSec Medical Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining OncoSec Medical's current stock value. Our valuation model uses many indicators to compare OncoSec Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OncoSec Medical competition to find correlations between indicators driving OncoSec Medical's intrinsic value. More Info.OncoSec Medical is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value OncoSec Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OncoSec Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OncoSec Medical's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates OncoSec Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in OncoSec Medical and how it compares across the competition.
About OncoSec Medical Valuation
The delisted stock valuation mechanism determines the current worth of OncoSec Medical on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of OncoSec Medical. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of OncoSec Medical based exclusively on its fundamental and basic technical indicators. By analyzing OncoSec Medical's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of OncoSec Medical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of OncoSec Medical. We calculate exposure to OncoSec Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to OncoSec Medical's related companies.OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey. Oncosec Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people.
8 Steps to conduct OncoSec Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates OncoSec Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct OncoSec Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain OncoSec Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine OncoSec Medical's revenue streams: Identify OncoSec Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research OncoSec Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish OncoSec Medical's growth potential: Evaluate OncoSec Medical's management, business model, and growth potential.
- Determine OncoSec Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate OncoSec Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
OncoSec Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as OncoSec Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.8 M | |
| Forward Price Earnings | 8.6655 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the OncoSec Medical information on this page should be used as a complementary analysis to other OncoSec Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Transaction History View history of all your transactions and understand their impact on performance |